Drug Shortage Report for LOTEMAX GEL

Last updated on 2022-06-23 History
Report ID 163369
Drug Identification Number 02435853
Brand name LOTEMAX GEL
Common or Proper name LOTEMAX GEL
Company Name BAUSCH & LOMB INC
Market Status MARKETED
Active Ingredient(s) LOTEPREDNOL ETABONATE
Strength(s) 0.5%
Dosage form(s) GEL
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5mg
ATC code S01BA
ATC description ANTIINFLAMMATORY AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2022-06-20
Estimated end date 2022-07-04
Actual end date
Shortage status Actual shortage
Updated date 2022-06-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1400 N GOODMAN STREET
ROCHESTER, NEW YORK
UNITED STATES 14609
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-06-23 French Compare
v1 2022-06-23 English Compare

Showing 1 to 2 of 2